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The 25-gauge transconjunctival sutureless vitrec-
tomy (25-G TSV) system offers several advantages
over the standard 20-gauge pars plana vitrectomy
(PPV). It has been primarily used to treat less com-
plicated vitreoretinal pathologic conditions, such as
macular hole (MH) and epiretinal membrane (ERM)
(1), but as a result of the recent (and ongoing) im-
provement in 25-gauge microsurgical instruments,
more patients with complicated conditions are now
being considered candidates for 25 -G TSV (2).
Studies have reported expanding applications and
low rates of complication with 25-G TSV.3 However,
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some complications are specifically related to the
sutureless vitrectomy (4-6). Wound leakage and hy-
potony with choroidal detachment are the most com-
mon complications (7, 8) and the risk of more seri-
ous complications such as endophthalmitis may be
greater due to the unsutured sclerotomy sites (9).
Among the possible explanations for the self-sealing
nature of transconjunctival sutureless sclerotomies
are small wound size, internal vitreous plugging of
small wounds, and covering of overlying conjunctiva
and Tenon’s capsule (1, 10, 11). Recently, it was re-
ported that oblique insertion of a 25-gauge cannula
reduced the incidence of postoperative hypotony (10,
11). A special concern was directed to the higher
possibility of wound sealing-related complications in
the complicated vitreoretinal pathologies managed
with 25-G TSV, since the extensive peripheral vitrec-
tomy often needed in such cases is considered to be
a risk factor for postoperative hypotony (12, 13). In
addition, Lakhanpal et al . suggested that the more
extensive intraocular manipulation required in these
patients, predisposed to transient hypotony (13). A
possible delay in wound healing in patients with dia-
betes mellitus is another concern if a sutureless tech-
nique is used (2). Moreover, diabetic patients have
an altered immunity at various levels and may be
more susceptible to infection after ocular surgery
(14). Accordingly, this risk become higher after
leaving wounds without sutures. So it was very im-
portant and useful to investigate the incidence of
such wound sealing-related complications of 25-G
TSV in eyes with complicated pathology as prolifera-
tive diabetic retinopathy (PDR) and compare them
with simple non diabetic eyes as those with ERM
and MH as a control group.
PATIENTS AND METHODS
Design
A retrospective comparative case series study was
performed on patients underwent primary 25-G TSV
for the management of vitreoretinal complications
of PDR from September 2006 to May 2009 and for
non diabetic simple macular pathology (SMP) as
ERM and MH from June 2006 to march 2010.
Patients
We reviewed the medical records of 377 eyes of
349 patients with PDR (n=189 eyes of 164 patients)
or SMP (n=188 eyes of 185 patients) who under-
went primary 25-G TSV.
Patients were recruited from the vitreoretinal clin-
ics at Tokushima University Hospital, Ophthalmol-
ogy Department, Tokushima, Japan. Informed con-
sent was obtained form all patients before vitrectomy
which was done by 3 surgeons. The study was con-
ducted in accordance to the tenets of the Declaration
of Helsinki of Human studies.
Inclusion criteria
Patients with SMP as ERM or MH or vitreoreti-
nal complications of PDR as unresolved vitreous
hemorrhage (VH), tractional retinal detachment
(RD) and progressive fibrovascular proliferations re-
quiring a primary vitrectomy.
Exclusion criteria
Eyes with prior vitreous surgery, glaucoma fil-
tration surgery, patients with inadequate follow up
and eyes with intraoperative injection of silicone oil
tamponading agent.
Methods
Patients medical records were reviewed and the
following data were collected : age, gender, intraocu-
lar pressure (IOP), which was measured preopera-
tively and on the 1st , 5th day, 1st, 3rd and 6th postop-
erative months using Goldmann applanation tonome-
ter (the mean IOP of 3 successive measurements
was taken). The degree of postoperative anterior
chamber (AC) inflammation was also collected ; it
was graded qualitatively by slit-lamp examination
(anterior chamber cell count, presence or absence
of flare and/or fibrin formation). Lens status, in-
traoperative vitreous fill, suture use, intraoperative
and postoperative complications were also recorded
with a special attention to wound sealing-related
complications.
Patients who met the inclusion criteria were fol-
lowed for at least 1 month which was considered
by us to be the maximum period for occurrence of
wound sealing-related complications. Patients who
did not complete their follow up visits or underwent
another surgery after the 1st postoperative month
were excluded from 3rd or 6th month data analysis.
SURGICAL TECHNIQUE
All patients underwent a standardized surgical
procedure for vitrectomy combined or not with pha-
coemulsification and intraocular lens (IOL) implanta-
tion under retrobulbar anesthesia. In cases when
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phacoemulsification was combined with vitrectomy,
it was performed before the vitrectomy after can-
nula insertion. All patients underwent primary 25-
G TSV with the newly designed 25-gauge titanium
Naito microcannula system (Duckworth & Kent
Inc., Hertfordshire, UK) which has a precision en-
gineered step in the cannula to prevent slippage.
The conjunctiva and Tenon capsule were displaced
over the sclera to avoid communication between
the conjunctival and scleral entry sites and to mini-
mize the risk of postoperative fluid leakage. The
conjunctiva was fixed to the sclera with a fixation
ring (Duckworth & Kent Inc., Hertfordshire, UK)
and the incisions were made by inserting a 25 -
gauge microvitreoretinal blade (Bauch & Lomb
Inc., Rochester, USA) at a 30to 40angle through
the conjunctiva, sclera and the pars plana 3.5-4
mm posterior to the limbus. The newly designed
25-gauge Naito microcannulas were inserted through
the conjunctival incision and the scleral tunnel us-
ing a cannula inserter (Duckworth & Kent Inc.,
Hertfordshire, UK). The infusion catheter was con-
nected to the inferotemporal microcannula (which
was the first to be inserted and the last to be re-
moved) and turned off till the beginning of the
vitrectomy procedure. Scleral tunnel lens surgery
with intraocular lens implantation was then per-
formed for all cases with visually significant cata-
ract which would preclude adequate fundus visu-
alization for operative procedure and for postopera-
tive care and also in all cases aged over 50 to avoid
postoperative cataract progression. In both groups
a core vitrectomy and vitrectomy around sclerotomy
sites were performed. Intravitreal injection of triam-
cinolone acetonide (TA) (Kenacort-A ; Bristol Myers
Co Ltd, Tokyo, Japan ; 4 mg/0.1 ml) was injected
over the posterior pole for better visualization and
complete removal of the posterior cortical vitreous.
In eyes with no preoperative posterior vitreous de-
tachment (PVD), the posterior hyaloid membrane
was detached at the optic disc by aspiration using
a vitreous cutter. In eyes with PDR, dissection and
removal of proliferative fibrovascular and epiretinal
membranes was performed efficiently using 25-G
forceps, scissors and cutter. Transvitreal diathermy
was used to coagulate bleeding vessels. Peripheral
shaving of the vitreous base was then performed
using indentation. The peripheral retina was checked
at the same time for any breaks or fibrovascular
tissue. A directional endolaser was used with in-
dentation for panretinal photocoagulation (PRP) and
to seal around retinal breaks : either iatrogenic,
detected during peripheral internal search or in
cases with tractional rhegmatogenous RD.
In eyes with simple macular pathology, ERM
was removed, with or without internal limiting mem-
brane (ILM) peeling. In eyes with macular hole,
ILM peeling was performed in all cases with indo-
cyanine green injection (0.125%). All vitrectomies
were performed with careful 360scleral depres-
sion to assist peripheral retinal examination and to
facilitate trimming the anterior as well as posterior
vitreous base. For both groups, fluid-gas exchange
with perfluoropropane (C3F8 12% to 16%), fluid-air
exchange or no exchange were done according to
the surgical indication or surgeon’s preference. Fi-
nally, microcannulas were removed from the scleral
tunnels. The infusion cannula was the last to be re-
moved to maintain the stability of the globe, the con-
junctiva was pushed laterally using a cotton wool
applicator to separate its incision from the scleral
incision and pressure was applied over the sclera
for wound closure for a few seconds to promote
wound seal. At the end of the case, all sclerotomy
sites were inspected to detect bleb formation or
any frank leakage that may require suture place-
ment. Subconjunctival injections of antibiotics and
steroid were given and antibiotic eye ointment was
applied at the conclusion of surgery. Main outcome
measures were : 1) Preoperative and postoperative
IOP 2) Postoperative inflammation and 3) Postop-
erative wound sealing-related complications and
4) The correlation between postoperative hypotony
and preoperative eye disease.
STATISTICAL ANALYSIS
Visual acuities were measured with a Landolt C
chart and then converted to the logarithm of the
minimum angle of resolution (logMAR) equivalents
for statistical analysis. All data were statistically ana-
lyzed using the paired Student’s t test and independ-
ent samples t test when appropriate ; using SPSS
software for Windows, with a P value of less than
0.05 was considered to be statistically significant. Bi-
variate relationships were examined using Pearson
correlation test or by Spearman correlation test. Z
test was used to compare between proportions of
the 2 groups. Hypotony was defined as an IOP of
less than 8 mmHg as it was defined in previous stud-
ies (15, 16). High IOP was defined as IOP of22
mmHg considering 21 mmHg as the upper limit of
normal. Anterior chamber cell grading was done
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according to the SUN (Standardization of Uveitis
nomenclature) working group grading scheme for
anterior chamber cells (17) as follows : 0=1 cell,
0.5+ =1-5 cells, 1+ =6-15 cells, 2+ =16-25 cells, 3+ =
26 - 50 cells, 4+ =50 cells.
RESULTS
Patients characteristics
Three hundred seventy seven (377) eyes of 349
patients met the inclusion criteria and underwent
1ry 25-G TSV for the management of SMP or the
vitreoretinal complications of PDR. The patient
demographics and base line preoperative data for
all patients are summarized in (Table 1).
There was a female predominance in SMP group
(P=0.00) and a significantly younger age and a
higher preoperative mean IOP (P=0.00) in PDR
group than SMP group. Such differences were ex-
pected from the natural occurrence, and pathophysi-
ology of each disease which will not affect our sta-
tistical analysis of data as we will compare the post-
operative results of each group with its own base-
line values ; not with results from the other group.
The follow up period was for at least 1 month range
(range 1-6 months). Surgical indications for vitrec-
tomy in PDR group were vitreous hemorrhage, trac-
tional retinal detachment, progressive fibrovascular
proliferations and tractional rhegmatogenous retinal
detachment. For SMP group, surgical indications
were idiopathic or secondary ERM, idiopathic or
traumatic MH, MH with ERM and macular schisis.
Intraoperative results
In PDR group, endodiathermy was used to con-
trol bleeding during membrane dissection in 14
eyes (7%). Directional endolaser with indentation
was used for supplementary or primary panretinal
photocoagulation in all cases with a mean number
of spots of 1002678.3. Retinotomy was required
in 2 eyes only (1%) and subretinal strand removal
in 2 eyes (1%). In SMP group, intraoperative, small
petechiae from the perifoveal capillary bed were
noted during ERM removal in 28 eyes (27%) and
in 2 cases of MH during ILM peeling. However, in
all cases, this phenomenon was always readily con-
trolled simply by temporarily elevating the intraocu-
lar pressure and it had no effect on the early or fi-
nal visual outcomes. Most of these petechiae com-
pletely disappeared before the 1st postoperative
month. Posterior vitreous detachment was surgically
induced in 115 (61%) eyes with SMP. Epiretinal
membranes were successfully removed from the fo-
vea in all except 10 (10%) eyes where residual mem-
brane was left in the macular area, far from the fo-
vea. Successful macular hole closure had been
achieved in 78 (91%) eyes by the time of the 6
month follow up visit. In both groups, all intraop-
erative breaks were treated by intraoperative en-
dolaser photocoagulation and if necessary, gas tam-
ponade. At the conclusion of surgery, there was
no significant difference between both groups as
regard the number of fluid filled eyes (58% vs 52%)
or eyes with air/gas tamponade (42% vs 48%) for
PDR and SMP groups respectively (P=0.1). There
Table 1. Patients Demographics
Characteristic PDR SMP P -value
Eyes 189 188 0.47
Male 119 78 0.00*
Female 70 110 0.00*
Average age(yrs) 56.8111.42 66.118.63 0.00*
Preop. IOP 15.224.77 14.013.39 0.005*
Phakic 164 (87%) 172(91%) 0.07
Pseudoph. 25 (13%) 16 (9%) 0.07
PDR=proliferative diabetic retinopathy ; SMP=simple macular pathology ; OD=right eye ; OS=left eye ; Preop.=preoperative ; IOP=
intraocular pressure.
Values are expressed in number of eyes
Age, IOP are presented as meanstandard deviation (SD)
Z-test to compare between 2 proportions
* P -value is statistically significant
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was no statistically significant differences between
both groups regarding the intraoperative complica-
tions (P.05) except for the incidence of intraop-
erative retinal breaks, which was significantly higher
in the PDR group (P=0.00). We did not recognize
any intraoperative technical problems or any in-
traoperative complications related to small gauge
instrumentation such as deformation of the micro-
cannula, disconnection of the infusion cannula or
breakage of the vitreous cutter in either groups. No
patients in either group required a suture at the
sclerotomy site because of leakage and no scleroto-
mies were converted to the 20-gauge procedure for
the management of existing surgical pathology or
intraoperative complications.
Postopertaive results
In both groups, the mean baseline logMAR BCVA
improved significantly at the 1st, 3rd and 6th month
postoperative visits (P=0.000). In PDR group, the
mean IOP at the 1st postoperative day was higher
(15.777.88) than the baseline values (15.22
4.77), albeit insignificant (P=0.161), this was not
the case for the SMP group, where the mean day
1 IOP (12.936.33) was significantly lower than the
baseline preoperative values (14.013.39 ; P=0.02),
(Figure 1). We reported a significant decrease in
the mean IOP on the 5th postoperative day com-
pared to baseline values for both groups (13.48
5.96 mmHg) and (12.724.28 mmHg) for PDR and
SMP groups respectively. Postoperative IOP re-
turned closer to the baseline levels in both groups
by the 1st postoperative month (Figure 1) and there-
after. As the mean preoperative IOP was signifi-
cantly higher for PDR group, we were not able to
compare between both groups in terms of postop-
erative IOP, but when we made a subgroup analy-
sis we found that, the mean preoperative IOP for
gas/air filled eyes in both groups was comparable
(15.364.3 and 14.423.29) for PDR and SMP
groups respectively (P=0.08), allowing us to com-
pare the postoperative IOP in this subgroup in both
main groups (Figure 2).
We found a significantly higher mean IOP for
PDR group at the 1st postoperative day (15.777.89
mmHg) than for SMP group (13.436.68 mmHg ;
P= 0.023) but not thereafter (Figure 2).
The mean postoperative anterior chamber cell
grading was significantly higher in PDR group than
in SMP group at the postoperative day 1 (2.27
0.93 vs 1.480.96 ; P=0.00) and day 5 (1.590.96
vs 0.970.79 ; P=0.00) but not thereafter. In PDR
Figure 1. Comparing preoperative & postoperative mean IOP for each group after exclusion of silicon oil filled eyes.
IOP=intraocular pressure ; PDR=proliferative diabetic retinopathy ; SMP=simple macular pathology ; Preop.=preoperative ; D1=1st
postoperative day ; D5=5th postoperative day ; M1=1st postoperative month.
*P -value is statistically significant
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group anterior chamber cell grading was signifi-
cantly higher at the postoperative day 1 than day 5
(2.270.92 vs 1.590.96 ; P=0.00).
At the 1st postoperative day, PDR group showed
a significantly higher incidence of anterior chamber
flare (23% vs 6% ; P=0.00) and fibrin (12% vs 2% ;P=
0.00), (Figure 3) the same was at the postoperative
day 5 (16% vs 4% for flare ; P=0.00 and 7% vs 0.5%
for fibrin ; P=0.00) for PDR and SMP group respec-
tively.
The higher postoperative day 1 IOP was corre-
lated with the presence of PDR pathology (r=0.219,
P=0.00) and with postoperative day 1 anterior cham-
ber cell grading (r=0.192, P=0.00). Also, the higher
postoperative day 1 anterior chamber cell grading
was correlated with the presence of PDR pathology
(r=0.385, P=0.00). Absence of hypotony also was
correlated to the presence of PDR pathology (r=
0.14,P=0.007). No correlations were found between
the postoperative day 1 IOP and preoperative IOP,
type of vitreous filling or the age of the patient.
The incidence of early postoperative complications
which were attributed to the sutureless technique
itself are summarized in table 2, (Figure 3). Post-
operative bleb was defined as subconjunctival fluid
collection indicating subconjunctival fluid leakage
which may, or may be not associated with external
leakage (positive Seidle test). Proliferative diabetic
Figure 3. Percentage of the 1st postoperative day inflammation, high IOP and wound-sealing related complications in both groups
PDR=proliferative diabetic retinopathy ; SMP=simple macular pathology ; IOP=intraocular pressure ; CD=choroidal detachment ;
subconj.=subconjunctival
*P -value is statistically significant
Figure 2. Comparing preoperative & postoperative mean IOP in air/gas filled eyes between both groups
IOP=intraocular pressure ; PDR=proliferative diabetic retinopathy ; SMP=simple macular pathology ; Preop.=preoperative ; D1=1st
postoperative day ; D5=5th postoperative day ; M1=1st postoperative month.
*P -value is statistically significant
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retinopathy group showed a significantly lower in-
cidence of day 1 hypotony, choroidal detachment,
external leakage and conjunctival bleb formation
on the 1st postoperative day than SMP group (P
0.05), however, there was no significant difference
between both groups in the incidence of theses
complications at the 5th postoperative day or there-
after. No eyes with external leakage were noted in
PDR group. All cases of postoperative wound seal-
ing-related complications in both groups passed
uneventually, none of them required scleral sutur-
ing or air infusion. On the other hand, we reported
a significantly higher incidence of the 1st postop-
erative day high IOP (22 mmHg) in PDR group
(15.5%) compared to (4%) only in SMP group (P=
0.000), no significant difference was found thereaf-
ter (Figure 3).
There were no cases of early or late postoperative
endophthalmitis in either of the 2 study groups,
however, there was one eye in each group suf-
fered from sterile (non-infectious) postoperative en-
dophthalmitis on the 1st and 5th postoperative days
(for SMP and PDR groups respectively). This was
suggested to be a reaction to the intraoperatively
injected intravitreal triamcinolone (after exclusion
of microbial causes by culture and sensitivity). Both
patients were successfully treated with the use of
topical and systemic steroids.
DISCUSSION
Wound sealing related complications as wound
leakage and hypotony with choroidal detachment
were recorded previously to be the most common
complications related to the 25-G TSV (7, 8). Some
factors were reported to be protective against or mini-
mize the occurrence of wound sealing complications
following sutureless vitrectomy as the older patient
age (18), angled sclerotomy (10, 11), absence of pre-
vious vitrectomy,3 minimal peripheral vitrectomy,12,13
minimal manipulation, short operating times and
small wound size (1, 10-13). On the other hands,
straight sclerotomy incision (10, 11), young patients
(18), extensive peripheral vitrectomy (12, 13), ex-
tensive intraocular manipulation (13, 19), previous
vitrectomy (3) and long operation times were re-
ported to be associated with a higher incidence of
wound sealing related complications. These risk fac-
tors are mostly associated with the complicated vit-
reoretinal pathologies as PDR and so eyes with PDR
are theoretically susceptible to a higher risk of
wound sealing related complications. Accordingly it
was so important to investigate the incidence of such
complications in eyes with PDR and to compare
them with a control group as SMP group. In our
study, both groups were equal in the presence of
some protective factors against hypotony regarding
the small wound size, angled sclerotomy and pri-
mary vitrectomy. However, risk factors were more
in the PDR group regarding the younger patients’
age, extensive peripheral vitrectomy, extensive in-
traocular manipulation and longer operating times
which theoretically would expose them to an in-
creased risk of postoperative wound sealing related
complications. This was not noted in our study but
the reverse happened. Interestingly, the group of the
complicated PDR pathology showed a significantly
lower incidence of the 1st postoperative day hy-
potony and wound sealing related complications
than the SMP group. The postoperative day 1 was
reported previously to have the peak incidence of
hypotony and hypotony related complications (20).
At the same time the PDR group showed a signifi-
cantly higher postoperative inflammation and IOP at
the same day than SMP group, both were correlated
Table 2. Postoperative wound sealing related complications in both groups
1st postoperative day 5th postoperative day
Early postoperative complications PDR SMP P -value PDR SMP P -value
Hypotony 18(9%) 35(18%) 0.000* 15(8%) 14(7%) 0.47
Choroidal detachment 0(0%) 4(2%) 0.02* 2(1%) 1(0.5%) 0.29
External leakage (+ve Seidle) 0(0%) 3(2%) 0.04* 0(0%) 0(0%)
Bleb formation 2(1%) 16(8%) 0.000* 3(2%) 7(4%) 0.09
Subconjunctival gas 2(1%) 1(0.5%) 0.29 1(0.5%) 1(0.5%) 0.49
Endophthalmitis 0(0%) 0(0%) 0(0%) 0(0%)
PDR=proliferative diabetic retinopathy ; SMP=simple macular pathology ; +ve=positive.
Values are presented as number of eyes (%)
Z-test to compare between 2 proportions
*P-value is statistically significant
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with each other and with the PDR pathology.
We can explain our results as follows : the post-
operative diabetic eye experiences more severe post-
operative inflammation than a non diabetic one. In-
flammation is one of the important processes in
wound healing and some postoperative inflamma-
tion is inevitable in any surgery (20). In general,
PPV may cause the breakdown of blood-ocular bar-
rier, but the underlying microangiopathy of eyes
with PDR may aggravate the postoperative changes
due to increased capillary leakage (20, 21) and thus
results in much more tissue edema and uveal tract
congestion. A stronger inflammatory response was
reported to be associated with phacovitrectomy more
than vitrectomy alone for diabetic eyes (22). In ad-
dition, cataract removal in diabetic patients can
upregulate the angiogenic and proinflammatory cy-
tokines in the anterior chamber (23). In our study,
other potential causes for short-term IOP rises may
include choroidal edema and alterations in ciliary
body function related to inflammation (24) which
may be aggravated in our study due to the perform-
ance of endolaser photocoagulation for all eyes with
PDR with a mean number of shots of (1002678.3).
Endolaser photocoagulation could contribute to IOP
elevation in PDR group in the early postoperative
period by several possible mechanisms including
breakdown of the blood-retinal barrier with leakage
of fluid into the eye. Abnormal leakage of fluid into
the eye would raise pressure in a manner similar to
an increase in aqueous formation (25). A second
possible mechanism is a decreased uveoscleral out-
flow due to congestion of the ciliary body. Laser
damage to the short ciliary nerves that innervate the
ciliary muscle causing decreased ciliary muscle tone
and a resulting impairment of outflow facility may
be a third possibility. Finally, IOP rise due to the re-
lease of prostaglandins was previously reported (25).
The combination of higher postoperative IOP and
inflammation may affect wound sealing by the fol-
lowing mechanisms : inflammation leads to uveal
congestion which in turn seems to bring the lips of
the internal orifice (uveal side) of the sclerotomy
incision into a more approximate position, making
it narrower than the outer scleral orifice thus, it be-
comes less prone to leakage. The analysis of our
results support this mechanism, as the significantly
lower incidence of wound sealing-related complica-
tions is evident for PDR group only on the postop-
erative day one when the postoperative inflamma-
tion was at its peak. Once the postoperative inflam-
mation appeared to settle down, eyes with PDR
behaved in a similar way as did those of the SMP
group and the IOP drops significantly than preop-
erative levels at the postoperative day 5. In our
study, although the postoperative inflammations in
PDR group was also significantly higher than SMP
group at the postoperative day 5, its effect did not
appear at the 5th postoperative day because it was
also significantly lower than the 1st postoperative
day inflammation levels for PDR group. The 2nd
explanation is that, the higher early postoperative
IOP in diabetic eyes due to postoperative inflamma-
tion and endolaser photocoagulation as described
above increases the appositional forces of the an-
gled sclerotomy. This mechanism is supported by
the study of Taban et al . (19) when they reported
that, there are important variables that contribute to
the dynamic morphology of sclerotomies in the early
postoperative period, namely the incision angle and
IOP which act together to determine the wound
structure and thus wound gapping, leakage and en-
dophthalmitis and they found that, angled (beveled)
incisions provide better wound apposition under dy-
namic IOP conditions. In our study, the 1st postop-
erative day mean IOP was significantly higher in
PDR group and high IOP tended to compress
against the scleral tunnel from inside making it
more angled and more slit-like. Once the effect of
endolaser photocoagulation and postoperative in-
flammation on IOP had gradually subsided, the IOP
of PDR group began to follow the natural course of
the control group.
Our study also revealed that there was no corre-
lation between the postoperative day 1 IOP and the
age of the patient, type of vitreous filling or the pre-
operative IOP values. In contrast to previous reports
that found correlations between wound leakage and
both younger patient age (18) and fluid filled eyes
(8). this discrepancy in results may be because the
relatively younger age in PDR group was not so
young but in the middle age. Also the use of angled
scletotomies in all eyes in our study make the effect
of vitreous filling on postoperative hypotony and
leakage irrelevant. We conclude that, although a
stronger postoperative inflammation and a higher
IOP tend to occur more in diabetic than in non-
diabetic eyes on the 1st postoperative day, they ap-
pear to act as a protective factor against the occur-
rence of postoperative wound sealing-related com-
plications and it means that diabetic eyes are overall
exposed to a shorter period of low IOP as these fac-
tors increase the likelihood of wound sealing until
the point at which natural wound healing takes place
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(between 1-2 weeks postoperatively) (19, 26). This
study demonstrates a statistical strength over the
previously published reports. To the author’s best
knowledge, this study is the 1st to investigated
wound sealing-related complications in eyes with
PDR and to compare these results with a control
group. It has revealed a new concept regarding the
less incidence of such well-known complications re-
lated to sutureless vitrectomy in eyes with PDR due
to the different postoperative behavior in such eyes.
Our results add more information regarding the
safety and decreased incidence of the most com-
mon complications of 25-G TSV in eyes with PDR.
Moreover, the 25-G TSV was done by the same sur-
geons in both groups thus eliminating operator bias.
Further work in this area should involve an anterior
chamber optical coherence tomography study of the
wound architecture on the day after vitrectomy for
PDR and non diabetic patients to confirm the effect
of postoperative inflammation on the swelling and
approximation of the lips of the internal orifice
(uveal side) of the sclerotomy incision as well as the
effect of the high postoperative IOP on the modifi-
cation of the architecture and beveling of the angled
incision.
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